Patent · US Active

1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives

US7888380B2 · kind B2 · utility

1Cited by

2References

27Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Shenlin Huang · Raritan, US
Ronghui Lin · Ambler, US
Peter J. Connolly · New Providence, US
Stuart Emanuel · Doylestown, US
Steven A. Middleton · Flemington, US
Robert H. Gruninger · Easton, US
Steven K. Wetter · Flemington, US

Key dates

Filing date	Oct 6, 2005
Grant date	Feb 15, 2011
Priority date	—
Expiry date	Sep 5, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D249/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

1,2,4-Triazolylaminoaryl(heteroaryl)sulfonamide derivatives of formula (I), pharmaceutically acceptable salts thereof, processes for the manufacture of 1,2,4-triazolylaminoaryl(heteroaryl)sulfonamide derivatives and pharmaceutical compositions containing 1,2,4-triazolylaminoaryl(heteroaryl)sulfonamide derivatives are disclosed:The 1,2,4-triazolylaminoaryl(heteroaryl)sulfonamide derivatives of formula (I) possess cell cycle inhibitory activity and are accordingly useful for their anti cell proliferation (such as anti cancer) activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.